These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 2538770)
21. Behavioral differences in an elevated plus-maze: correlation between anxiety and decreased number of GABA and benzodiazepine receptors in mouse cerebral cortex. Rägo L; Kiivet RA; Harro J; Pŏld M Naunyn Schmiedebergs Arch Pharmacol; 1988 Jun; 337(6):675-8. PubMed ID: 2851107 [TBL] [Abstract][Full Text] [Related]
22. Neurotransmitter-mediated anxiogenic action of PACAP-38 in rats. Telegdy G; Adamik A Behav Brain Res; 2015 Mar; 281():333-8. PubMed ID: 25543171 [TBL] [Abstract][Full Text] [Related]
23. FG7142, yohimbine, and βCCE produce anxiogenic-like effects in the elevated plus-maze but do not affect brainstem activated hippocampal theta. Yeung M; Lu L; Hughes AM; Treit D; Dickson CT Neuropharmacology; 2013 Dec; 75():47-52. PubMed ID: 23851259 [TBL] [Abstract][Full Text] [Related]
25. Role of benzodiazepine receptors located in the dorsal periaqueductal grey of rats in anxiety. Russo AS; Guimarães FS; De Aguiar JC; Graeff FG Psychopharmacology (Berl); 1993; 110(1-2):198-202. PubMed ID: 7870885 [TBL] [Abstract][Full Text] [Related]
26. 5-HT1A and benzodiazepine receptors in the basolateral amygdala modulate anxiety in the social interaction test, but not in the elevated plus-maze. Gonzalez LE; Andrews N; File SE Brain Res; 1996 Sep; 732(1-2):145-53. PubMed ID: 8891278 [TBL] [Abstract][Full Text] [Related]
28. The effects of moclobemide on the yohimbine-induced anxiogenic action in the elevated plus-maze. Eroğlu L; Güven O Pharmacol Res; 1998 Feb; 37(2):137-43. PubMed ID: 9572069 [TBL] [Abstract][Full Text] [Related]
29. Does the benzodiazepine antagonist Ro 15-1788 reverse the actions of picrotoxin and pentylenetetrazole on social and exploratory behaviour? File SE; Pellow S Arch Int Pharmacodyn Ther; 1985 Oct; 277(2):272-9. PubMed ID: 2865937 [TBL] [Abstract][Full Text] [Related]
30. Chlordiazepoxide enhances the anxiogenic action of CGS 8216 in the social interaction test: evidence for benzodiazepine withdrawal? File SE; Pellow S Pharmacol Biochem Behav; 1985 Jul; 23(1):33-6. PubMed ID: 3929278 [TBL] [Abstract][Full Text] [Related]
31. Yohimbine's anxiogenic action: evidence for noradrenergic and dopaminergic sites. Johnston AL; File SE Pharmacol Biochem Behav; 1989 Jan; 32(1):151-6. PubMed ID: 2567522 [TBL] [Abstract][Full Text] [Related]
32. Effects of a single or repeated administration of the benzodiazepine inverse agonist FG7142 on behaviour and cortical adrenoceptor binding in the rat. Stanford SC; Baldwin HA; File SE Psychopharmacology (Berl); 1989; 98(3):417-24. PubMed ID: 2546172 [TBL] [Abstract][Full Text] [Related]
33. On the elevated plus-maze the anxiolytic-like effects of the 5-HT(1A) agonist, 8-OH-DPAT, but not the anxiogenic-like effects of the 5-HT(1A) partial agonist, buspirone, are blocked by the 5-HT1A antagonist, WAY 100635. Collinson N; Dawson GR Psychopharmacology (Berl); 1997 Jul; 132(1):35-43. PubMed ID: 9272757 [TBL] [Abstract][Full Text] [Related]
34. Effect of phenobarbitone administration to pregnant rats on anxiety in offsprings. Singh KP; Singh M; Jaiswal AK Indian J Exp Biol; 1999 Nov; 37(11):1070-4. PubMed ID: 10783737 [TBL] [Abstract][Full Text] [Related]
35. Behavioral and pharmacological validation of the elevated plus maze constructed with transparent walls. Anseloni VZ; Motta V; Lima G; Brandão ML Braz J Med Biol Res; 1995 May; 28(5):597-601. PubMed ID: 8555981 [TBL] [Abstract][Full Text] [Related]
36. Ethopharmacological analysis of the effects of putative 'anxiogenic' agents in the mouse elevated plus-maze. Rodgers RJ; Cole JC; Aboualfa K; Stephenson LH Pharmacol Biochem Behav; 1995 Dec; 52(4):805-13. PubMed ID: 8587923 [TBL] [Abstract][Full Text] [Related]
37. GABA-A receptor modulators alter emotionality and hippocampal theta rhythm in an animal model of long-lasting anxiety. Hoeller AA; Duzzioni M; Duarte FS; Leme LR; Costa AP; Santos EC; de Pieri CH; dos Santos AA; Naime AA; Farina M; de Lima TC Brain Res; 2013 Sep; 1532():21-31. PubMed ID: 23911836 [TBL] [Abstract][Full Text] [Related]
38. Validation of a modified mirrored chamber sensitive to anxiolytics and anxiogenics in mice. Kliethermes CL; Finn DA; Crabbe JC Psychopharmacology (Berl); 2003 Sep; 169(2):190-7. PubMed ID: 12783153 [TBL] [Abstract][Full Text] [Related]
40. Evidence for simultaneous anxiolytic and aversive effects several hours after administration of sodium phenobarbitone to the rat. Wilks LJ; File SE Neuropsychobiology; 1988; 19(2):86-9. PubMed ID: 3226528 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]